Natalizumab Extended Interval Dosing: Real Life Experience

被引：0
|
作者：
Jacques, Francois [1 ]
Lebel, Marie-Christine [1 ]
Timite, Halilou [1 ]
机构：
[1] Clin Neuro Outaouais, Neurol, Gatineau, PQ, Canada
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1597/1556
引用
收藏
页码：1016 / 1017
页数：2
相关论文
共 50 条
  • [1] Natalizumab extended-interval dosing in a real-life setting
    Jeantin, Lina
    de la Motte, Marine Boudot
    Deschamps, Romain
    Gueguen, Antoine
    Gout, Olivier
    Lecler, Augustin
    Papeix, Caroline
    Bensa, Caroline
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 450
  • [2] Extended Interval Dosing of Natalizumab: A Single Center Experience
    Alderazi, Yazan J.
    Campagnolo, Denise
    Bomprezzi, Roberto
    [J]. NEUROLOGY, 2011, 76 (09) : A614 - A614
  • [3] Natalizumab extended-interval dosing in a real-life context: efficacy study
    Jeantin, L.
    De la Motte, M. Boudot
    Chauvin, M.
    Dade, M.
    Deschamps, R.
    Gueguen, A.
    Mossad, M.
    Diallo, S. S.
    Gout, O.
    Bensa, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 852 - 853
  • [4] Natalizumab: extended versus standard interval dosing in the real world
    Wagner, B.
    Richter, S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 880 - 881
  • [5] Extended interval dosing of natalizumab in MS; a New Zealand experience
    Chan, Calvin
    Siu, Ronald
    Mellsop, Nick
    Schepel, Jan
    [J]. NEUROLOGY, 2018, 90
  • [6] Effectiveness of Natalizumab in Extended Dosing Interval
    Hervas, Jose Vicente
    Punet-Ortiz, Joan
    Teniente-Serra, Aina
    Mansilla, M. Jos
    Quirant-Sanchez, Bibiana
    Navarro, Juan
    Presas, Silvia
    Martinez-Caceres, Eva
    Ramo, Cristina
    [J]. NEUROLOGY, 2016, 86
  • [7] Effectiveness of natalizumab in extended dosing interval
    Ramo-Tello, C.
    Grau-Lopez, L.
    Vilaro, L.
    Segui, C.
    Delicado, S.
    Bonafont, X.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 213 - 214
  • [8] Real world effectiveness of Natalizumab extended interval dosing in a French cohort
    Pelle, J.
    Briant, A.
    Lebrun-Frenay, C.
    Cohen, M.
    Mondot, L.
    De Seze, J.
    Bigaut, K.
    Collongues, N.
    Kremer, L.
    Ricard, D.
    Bompaire, F.
    Sallansonnet-Froment, M.
    Ohlmann, C.
    Ciron, J.
    Biotti, D.
    Pignolet, B.
    Parienti, J.
    Defer, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 207 - 207
  • [9] Extended-interval dosing of natalizumab in NOVA
    Stuve, Olaf
    Tugemann, Bastian
    [J]. LANCET NEUROLOGY, 2023, 22 (03): : 199 - 200
  • [10] Pharmacodynamics of natalizumab extended interval dosing in MS
    Zhovtis Ryerson, Lana
    Li, Xiaochun
    Goldberg, Judith D.
    Hoyt, Tamara
    Christensen, Angel
    Metzger, Ryan R.
    Kister, Ilya
    Foley, John
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (02):
12345